Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
Authors: Grau-Rivera, Oriol1,2,3,4 (AUTHOR) ograu@barcelonabeta.org, Navalpotro-Gomez, Irene1,2,3 (AUTHOR), Sánchez-Benavides, Gonzalo1,3,4 (AUTHOR), Suárez-Calvet, Marc1,2,3,4 (AUTHOR), Milà-Alomà, Marta1,3,4,5 (AUTHOR), Arenaza-Urquijo, Eider M.1,3,4 (AUTHOR), Salvadó, Gemma1,3,4 (AUTHOR), Sala-Vila, Aleix1,3 (AUTHOR), Shekari, Mahnaz1,3,5 (AUTHOR), González-de-Echávarri, José Maria1,3 (AUTHOR), Minguillón, Carolina1,3,4 (AUTHOR), Niñerola-Baizán, Aida6,7 (AUTHOR), Perissinotti, Andrés6,7 (AUTHOR), Simon, Maryline8 (AUTHOR), Kollmorgen, Gwendlyn9 (AUTHOR), Zetterberg, Henrik10,11,12,13 (AUTHOR), Blennow, Kaj10,12 (AUTHOR), Gispert, Juan Domingo1,3,7 (AUTHOR), Molinuevo, José Luis1,14 (AUTHOR) jlmolinuevo@fpmaragall.org, for the ALFA Study (AUTHOR)
Source: Alzheimer's Research & Therapy. 2/17/2021, Vol. 13 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-021-00781-z